Skip to main content
. 2019 May 9;11(5):1039. doi: 10.3390/nu11051039
AD Alzheimer’s disease
AMPK 5’ adenosine monophosphate-activated protein kinase
APP amyloid precursor protein
b.w. body weight
C (+)-catechin
CNS central nervous system
ECG epicatechin-3-gallate
EDRF endothelium-derived relaxing factor
EGC epigallocatechin
EGCG (-)-epigallocatechin-3-gallate
G6Pase glucose-6-phosphatase
GC (-)-gallocatechin
GCG (-)-gallocatechin gallate
GK glucokinase
GLUT 2 and 4 glucose transporters type 2 and 4
HMG-CoA 3-hydroxy-3-methylglutaryl-coenzyme
IRS-1 insulin receptor substrate 1
MPO myeloperoxidase
MPTP N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
NO nitric oxide
N-Sase neutral sphingomyelin-specific phospholipase C
6-OHDA 6-hydroxyydopamine
PD Parkinson’s disease
PEPCK Phosphoenolpyruvate carboxykinase
PI3K phosphoinositide-3-kinase
PKC protein kinase C
PPARγ peroxisome proliferator-associated receptor
RCTs randomized controlled trials
ROS reactive oxygen species
sAPP soluble form of APP
SGLT 1 sodium-glucose co-transporter type 1
SOD SuperOxide Dismutase
STZ streptozocin
TAGs Triglycerides
TBARS thiobarbituric acid reactive substances
TF theaflavin
TFs theaflavins
TRs thearubigins